The Value of Vaccines: Building Economic Resilience

Canada is facing an aging workforce, productivity challenges, and sustained healthcare strain. While preventive health, specifically adult vaccination, can support healthy aging and preserve labour participation, it is frequently undervalued in public decision-making. Often treated as a short-term cost to manage rather than a strategic investment, adult vaccination is a key missing piece in Canada's economic and workforce strategy.

On June 15, 2026, our panel of experts in health, policy, economics, and patient advocacy came together to explore how transparent return-on-investment analyses can reposition adult vaccination as a credible policy and productivity solution.